Venus Remedies Limited (NSE: VENUSREM), ISIN INE411B01019 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
VENUSREM last traded at ₹1546.00 (-3.89%), with a 52-week range of ₹423.70 to ₹2043.15 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 41.76%, FIIs 2.92%, DIIs 0.89%, mutual funds 0.00%.
EquiSense Score (ECS): 87/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.